Home › SUNRAKSHAK › Filing
🔔 Get instant alerts when SUNRAKSHAK files quarterly results on BSE Start free trial →

With Reference to above subject please find attach herewith Investor Presentation of Q2 H1 FY27

Filed: 14 Nov 2026, 22:38 IST Exchange: BSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2 FY27 - Consolidated revenue grew 119.20% YoY to ₹265.17 crore in Q2 FY27 - EBITDA increased 98.26% YoY to ₹23.14 crore; margin 8.73%, +55 bps q-o-q - PAT rose 130.10% YoY to ₹16.00 crore; PAT margin improved to 6.03% - H1 FY27 revenue grew 119.93% YoY to ₹541.50 crore; PAT up 130.39% to ₹31.04 crore - FMCG capacity expanded to 20,840 tons/month; on track to achieve ₹1,000 crore revenue by FY28 - Shift from textile to FMCG-led growth; FMCG contributed 90.85% of revenue in Q2 FY27 - Focus on product mix improvement, operating leverage, and cost efficiencies for growth
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SUNRAKSHAK — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SUNRAKSHAK to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Sunrakshakk Industries India Ltd

Important. The summary above is generated automatically from Sunrakshakk Industries India Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.